According to recent filings covering the 90 days ending February 07, 2026, the three most significant insider holders at Neurocrine Biosciences are Director Kevin Charles Gorman (516.89K shares), Chief Executive Officer Kyle Gano (141.75K shares), Director Gary A Lyons (120.48K shares).
| Holder | Position | Shares | Report Date |
|---|---|---|---|
| Kevin Charles Gorman | 516,893 | 03 Feb, 2026 | |
| Kyle Gano | Chief Executive Officer | 141,754 | 03 Feb, 2026 |
| Gary A Lyons | 120,482 | 04 Dec, 2025 | |
| Dimitri E. Grigoriadis | Chief Research Officer | 82,273 | 12 Oct, 2021 |
| Eric Benevich | Chief Commercial Officer | 52,755 | 03 Feb, 2026 |
| Darin Lippoldt | Chief Legal Officer | 47,792 | 03 Feb, 2026 |
| Malcolm Lloyd-Smith | Chief Integration Officer | 42,337 | 08 Feb, 2023 |
| William H Rastetter | 40,360 | 06 Nov, 2025 | |
| Matt Abernethy | Chief Financial Officer | 37,097 | 03 Feb, 2026 |
| Eiry Roberts | Chief Medical Officer | 35,640 | 14 Feb, 2025 |
| Richard F Pops | 34,480 | 22 May, 2025 | |
| Julie Cooke | Chief Human Resources Officer | 27,602 | 03 Feb, 2026 |
| Jude Onyia | Chief Scientific Officer | 15,977 | 03 Feb, 2026 |
| Stephen A Sherwin | 12,542 | 03 Sep, 2025 | |
| George J Morrow | 7,068 | 26 Nov, 2025 | |
| Leslie V Norwalk | 6,239 | 17 Dec, 2025 | |
| Ingrid Delaet | Chief Regulatory Officer | 5,056 | 03 Feb, 2026 |
| David W. Boyer | Chief Corp. Affairs Officer | 4,713 | 03 Feb, 2026 |
| Johanna Mercier | 3,535 | 22 May, 2025 | |
| Shalini Sharp | 2,429 | 22 May, 2025 | |
| Christine A Poon | 1,435 | 22 May, 2025 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 31 Jan, 2026 | Kevin Charles Gorman | Common Stock | A | 5,142 | $0.00 | 519,738 | D | M |
| 31 Jan, 2026 | Kevin Charles Gorman | Common Stock | D | 2,845 | $136.06 | 516,893 | D | F |
| 31 Jan, 2026 | Darin Lippoldt | Common Stock | D | 1,335 | $136.06 | 47,792 | D | F |
| 31 Jan, 2026 | Darin Lippoldt | Common Stock | A | 2,373 | $0.00 | 49,127 | D | M |
| 31 Jan, 2026 | Kyle Gano | Common Stock | D | 1,580 | $136.06 | 141,754 | D | F |
| 31 Jan, 2026 | Kyle Gano | Common Stock | A | 2,927 | $0.00 | 143,334 | D | M |
| 31 Jan, 2026 | Eric Benevich | Common Stock | A | 2,294 | $0.00 | 54,047 | D | M |
| 31 Jan, 2026 | Eric Benevich | Common Stock | D | 1,292 | $136.06 | 52,755 | D | F |
| 31 Jan, 2026 | Matt Abernethy | Common Stock | A | 2,437 | $0.00 | 38,465 | D | M |
| 31 Jan, 2026 | Matt Abernethy | Common Stock | D | 1,368 | $136.06 | 37,097 | D | F |
| 31 Jan, 2026 | Julie Cooke | Common Stock | A | 1,741 | $0.00 | 28,599 | D | M |
| 31 Jan, 2026 | Julie Cooke | Common Stock | D | 997 | $136.06 | 27,602 | D | F |
| 31 Jan, 2026 | Jude Onyia | Common Stock | A | 238 | $0.00 | 16,119 | D | M |
| 31 Jan, 2026 | Jude Onyia | Common Stock | D | 142 | $136.06 | 15,977 | D | F |
| 31 Jan, 2026 | David W. Boyer | Common Stock | D | 1,189 | $136.06 | 4,713 | D | F |
| 31 Jan, 2026 | David W. Boyer | Common Stock | A | 2,096 | $0.00 | 5,902 | D | M |
| 31 Jan, 2026 | Ingrid Delaet | Common Stock | A | 801 | $0.00 | 5,531 | D | M |
| 31 Jan, 2026 | Ingrid Delaet | Common Stock | D | 475 | $136.06 | 5,056 | D | F |
| 16 Jan, 2026 | Kyle Gano | Common Stock | A | 1,812 | $35.99 | 142,219 | D | M |
| 16 Jan, 2026 | Kyle Gano | Common Stock | A | 34,588 | $35.99 | 174,995 | D | M |